期刊文献+

某三甲医院多重耐药菌感染现状及集束干预效果 被引量:20

Current situation of multidrug-resistant organism infection and efficacy of bundle intervention measures in a tertiary first-class hospital
下载PDF
导出
摘要 目的了解某三甲医院住院患者多重耐药菌(MDRO)感染现状,以及集束干预措施的防控效果。方法对2012—2014年该院发生MDRO感染的住院患者进行重点监测及集束干预。结果 2012—2014年共检出MDRO1 909株。2012—2014年MDRO检出率分别为30.69%、31.04%、29.40%,床旁干预率分别为81.02%、92.05%、94.23%,临床隔离落实率分别为69.97%、82.98%、93.04%;2012—2014年MDRO检出率比较,差异无统计学意义(P>0.05);MDRO床旁干预率、临床隔离落实率比较,差异均具有统计学意义(均P<0.05)。2012—2014年MDRO居前3位的分别为产超广谱β-内酰胺酶大肠埃希菌(ESBLs-EC)、多重耐药鲍曼不动杆菌(MDRAB)、产超广谱β-内酰胺酶肺炎克雷伯菌(ESBLs-KP)。结论通过多部门联动及强化现场督查等集束干预模式,促使MDRO医院感染管理更加规范,临床隔离落实率不断提高,有效预防和控制了MDRO在医院的传播。 ObjectiveTo understand the current situation of multidrugresistant organism (MDRO) infection in hospitalized patients in a tertiary firstclass hospital, as well as efficacy of bundle intervention measures on prevention and control of infection. MethodsHospitalized patients who were infected with MDROs in this hospital during 2012-2014 were monitored and conducted bundle intervention. ResultsIn 2012-2014, a total of 1 909 MDRO strains were isolated. The isolation rates of MDROs in 2012-2014 were 30.69%, 31.04%, and 29.40% respectively,bedside intervention rates were 81.02%, 92.05%, and 94.23% respectively,implementation rates of clinical isolation were 69.97%, 82.98%, and 93.04% respectively; MDRO isolation rates during 2012-2014 were not significantly different(P〉0.05);bedside intervention rates and implementation rates of clinical isolation were both significantly different(both P〈0.05). The top 3 isolated MDROs in 2012-2014 were extendedspectrum βlactamases(ESBLs)producing Escherichia coli, multidrugresistant Acinetobacter baumannii, and ESBLsproducing Klebsiella pneumoniae. ConclusionBundle intervention measures, such as multidepartment collaboration and strengthened onsite supervision, can promote more standardized management of healthcareassociated infection, enhance the implementation rate of clinical isolation, and effectively prevent and control the spread of MDRO in hospital.
作者 张萌 张辉文
出处 《中国感染控制杂志》 CAS 北大核心 2017年第2期169-172,共4页 Chinese Journal of Infection Control
关键词 多重耐药菌 医院感染 干预 效果评价 multidrug-resistant organism healthcare-associated infection intervention effect evaluation
  • 相关文献

参考文献6

二级参考文献102

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2任南,吴安华,冯丽,文细毛,易霞云,吕一欣,龚瑞娥,黄勋,王曼平.住院患者抗菌药物临床应用横断面调查[J].中华医院感染学杂志,2006,16(9):1048-1050. 被引量:209
  • 3Jarvis WR. The lowbury lecture The United States approach to strategies in the battle against healthcare-associated infections,2006 :transitioning from benchmarking to zero to lerance and clinician accountability [J]. J Hosp Infect, 2007, 65 Suppl2 : 3 -9.
  • 4吴美凤,曾妃.多药耐药菌信息一览表在科室院感管理中的应用[J].中国实用护理杂志,2012,28(2):233.
  • 5唐平,张勇昌,陈惠琴.住院患者双重及多药耐药菌感染的调查[J].中华医院感染学杂志,2009,8(6):418-419.
  • 6Arias C A, Murray B E. Antibiotic-resistant bugs in the 21 Stcentury a clinical super-challenge[J]. NEngl J Med, 2009, 360(5): 439-443.
  • 7Clinical and Laboratory Standards Institute. Performance 5tandardsfor antimicrobial susceptibility testing[S]. Tweenty-first informational supplement, 2013, 31(1): M100-S23.
  • 8Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 10Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.

共引文献782

同被引文献167

引证文献20

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部